Wombat Capital
Avik Maewall is a highly experienced investment banking professional currently serving as Vice President at Wombat Capital, specializing in healthcare investment banking with a focus on mergers and acquisitions, debt and equity financing, valuation, and strategic alliances. Avik holds an Executive MBA from Columbia Business School and London Business School, and previously worked at Catalent Pharma Solutions as a Corporate Finance Manager, where the focus was on biologics, cell therapy, and gene therapy. Earlier experience includes managing business operations at Maewall Dental Care, implementing practice automation and significantly increasing patient engagement. Avik holds a Bachelor's degree in Biomedical Engineering from Purdue University, complemented by minors in Sociology, Collaborative Leadership, and Entrepreneurship and Innovation.
This person is not in the org chart
This person is not in any teams
Wombat Capital
About Wombat Capital Founded in 2009, Wombat Capital is a cross-border investment banking and strategic advisory firm providing first class services to entrepreneurs, board of directors, financial investors, private and public companies. By leveraging the industry sector expertise of its bankers, Wombat Capital brings an in-depth understanding of a company's challenges, opportunities and drivers for success and seeks to secure the optimum value and outcome for its clients and their shareholders. Wombat Capital focuses on the lower middle market by providing the following advisory services: • M&A (buy-side and sell-side) • Debt and Equity Financing • Valuation and Fairness Opinion • Joint Venture • Strategic Alliances Industry focus: • Life Sciences and Healthcare: Pharma, Biotech, Contract Services & Outsourcing, Diagnostics, Medical Devices, Healthcare IT Wombat Capital has offices in New York and Paris. Wombat Capital Markets LLC is a registered broker-dealer and member of FINRA (www.finra.org) and SIPC (www.sipc.org). Check the background of our firm and professionals at FINRA Brokercheck (https://brokercheck.finra.org)